|
PER2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.334000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.380800E-01 |
| Normal-vs-Stage2 |
6.043100E-04 |
| Normal-vs-Stage3 |
1.500640E-03 |
| Normal-vs-Stage4 |
6.454300E-02 |
| Stage1-vs-Stage2 |
1.007550E-02 |
| Stage1-vs-Stage3 |
2.342400E-02 |
| Stage1-vs-Stage4 |
4.870000E-01 |
| Stage2-vs-Stage3 |
8.925200E-01 |
| Stage2-vs-Stage4 |
5.275800E-01 |
| Stage3-vs-Stage4 |
6.364600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.485600E-02 |
| Normal-vs-AfricanAmerican |
1.002190E-01 |
| Normal-vs-Asian |
2.14020000000037E-06 |
| Caucasian-vs-AfricanAmerican |
9.584600E-01 |
| Caucasian-vs-Asian |
2.375000E-04 |
| AfricanAmerican-vs-Asian |
2.027300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.684370E-01 |
| Normal-vs-Female |
2.118500E-02 |
| Male-vs-Female |
1.383410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.134000E-02 |
| Normal-vs-Extreme_Weight |
1.274430E-01 |
| Normal-vs-Obese |
3.194000E-01 |
| Normal-vs-Extreme_Obese |
1.637770E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.437400E-01 |
| Normal_Weight-vs-Obese |
2.404200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.148200E-01 |
| Extreme_Weight-vs-Obese |
6.262000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.470500E-02 |
| Obese-vs-Extreme_Obese |
4.360000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.175600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.136600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.255600E-03 |
| Normal-vs-Age(81-100Yrs) |
3.419600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.703000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.712800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.321800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.838700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.530600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.123400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.317600E-01 |
| Normal-VS-Type2 PRCC |
1.618490E-04 |
| Normal-VS-KIRP CIMP |
3.397900E-02 |
| Normal-VS-Unclassified PRCC |
3.615400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.86249999999788E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.742040E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.674000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.724400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.414220E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.756400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.243000E-04 |
| Normal-vs-N1 |
3.993800E-02 |
| Normal-vs-N2 |
7.78830000047748E-07 |
| N0-vs-N1 |
3.844200E-01 |
| N0-vs-N2 |
1.393760E-02 |
| N1-vs-N2 |
1.728360E-02 |
|
|
